JE

Jens Eckstein

Dr Eckstein has more than 20 years of venture capital experience in the biopharmaceutical industry and 10 years of operational experience in drug discovery and development. He is a Kauffman Fellow and a mentor for lifescience entrepreneurs and start-up teams in the area of innovative lifescience and healthcare information technology companies. Before joining Apollo Ventures, Dr Eckstein served as president of SR One for eight years. He is also co-founder and managing director of Action Potential Venture Capital. Previously, he was a general partner at TVM Capital. He is member of Risk Committee.

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
01/07/2420,988,095N/A838,095N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
01/07/24
Issued
250,000$0.055$13,750Conversion of securities
01/07/24
Exercise
250,000$0.055$13,750Conversion of securities
12/01/24
Issued
1,000,000$0.120$120,000Issue of securities
03/10/23
Issued
238,095$0.047$11,190Placement
03/10/23
Issued
238,095$0.084$19,999Placement